877 related articles for article (PubMed ID: 30303519)
1. Eszopiclone for insomnia.
Rösner S; Englbrecht C; Wehrle R; Hajak G; Soyka M
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010703. PubMed ID: 30303519
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
3. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
Liang L; Huang Y; Xu R; Wei Y; Xiao L; Wang G
Sleep Med; 2019 Oct; 62():6-13. PubMed ID: 31518944
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.
De Crescenzo F; D'Alò GL; Ostinelli EG; Ciabattini M; Di Franco V; Watanabe N; Kurtulmus A; Tomlinson A; Mitrova Z; Foti F; Del Giovane C; Quested DJ; Cowen PJ; Barbui C; Amato L; Efthimiou O; Cipriani A
Lancet; 2022 Jul; 400(10347):170-184. PubMed ID: 35843245
[TBL] [Abstract][Full Text] [Related]
5. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
6. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
8. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
Liira J; Verbeek JH; Costa G; Driscoll TR; Sallinen M; Isotalo LK; Ruotsalainen JH
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009776. PubMed ID: 25113164
[TBL] [Abstract][Full Text] [Related]
12. Listening to music for insomnia in adults.
Jespersen KV; Pando-Naude V; Koenig J; Jennum P; Vuust P
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD010459. PubMed ID: 36000763
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine for fibromyalgia in adults.
Welsch P; Bernardy K; Derry S; Moore RA; Häuser W
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012708. PubMed ID: 30080242
[TBL] [Abstract][Full Text] [Related]
14. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
16. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
[TBL] [Abstract][Full Text] [Related]
17. Eszopiclone: its use in the treatment of insomnia.
Monti JM; Pandi-Perumal SR
Neuropsychiatr Dis Treat; 2007 Aug; 3(4):441-53. PubMed ID: 19300573
[TBL] [Abstract][Full Text] [Related]
18. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
19. Mefloquine for preventing malaria during travel to endemic areas.
Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
[TBL] [Abstract][Full Text] [Related]
20. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
